Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28367479 | 1.00 | NAAA (0.47) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| SCHEMBL12244967 | 1.00 | NAAA (0.47) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| SCHEMBL21127012 | 1.00 | NAAA (0.47) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| SCHEMBL30744 | 1.00 | NAAA (0.47) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| SCHEMBL13226047 | 1.00 | NAAA (0.47) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| SCHEMBL13508226 | 1.00 | NAAA (0.47) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| Water SCHEMBL19542146 | 0.98 | NAAA (0.46) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| Ammonia Solution, Strong SCHEMBL5629068 | 0.98 | NAAA (0.46) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| SCHEMBL463020 | 0.98 | SMN1; SMN2 (0.47) | NAAASMN1; SMN2MEN1GAAKMT2A | |
| SCHEMBL223756 | 0.95 | NAAA (0.44) | NAAASMN1; SMN2MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115052914-A | Shelf life extended bulk polymerized polycycloolefin compositions as optical materials | 普罗米鲁斯有限责任公司 | 2022-09-13 | — | — | CN | disclosed |
| US-11230566-B2 | Shelf life mass polymerizable polycycloolefin compositions as optical materials | PROMERUS, LLC (US) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11230566-B2 | Shelf life mass polymerizable polycycloolefin compositions as optical materials | FOXO3, MRTO4, RRP15 | NAAA 4759/4885SMN1; SMN2 1537/4885MEN1 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.